359 related articles for article (PubMed ID: 25972096)
1. Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.
Gharavi R; Hedrich W; Wang H; Hassan HE
Pharm Res; 2015 Aug; 32(8):2477-502. PubMed ID: 25972096
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the impact of drug-drug interactions associated with opioids.
Pergolizzi JV
Am J Manag Care; 2011 Sep; 17 Suppl 11():S288-92. PubMed ID: 21999761
[TBL] [Abstract][Full Text] [Related]
3. Opioid pharmacokinetic drug-drug interactions.
Overholser BR; Foster DR
Am J Manag Care; 2011 Sep; 17 Suppl 11():S276-87. PubMed ID: 21999760
[TBL] [Abstract][Full Text] [Related]
4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Drug-Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation.
Ji B; Liu S; Xue Y; He X; Man VH; Xie XQ; Wang J
Drugs R D; 2019 Sep; 19(3):297-305. PubMed ID: 31482303
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and Disposition of Prescription Opioids: A Review.
DePriest AZ; Puet BL; Holt AC; Roberts A; Cone EJ
Forensic Sci Rev; 2015 Jul; 27(2):115-45. PubMed ID: 26227254
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
8. Transporters and drug therapy: implications for drug disposition and disease.
Ho RH; Kim RB
Clin Pharmacol Ther; 2005 Sep; 78(3):260-77. PubMed ID: 16153397
[TBL] [Abstract][Full Text] [Related]
9. Drugs and medicines in pregnancy: the placental disposition of opioids.
Malek A; Mattison DR
Curr Pharm Biotechnol; 2011 May; 12(5):797-803. PubMed ID: 21480827
[TBL] [Abstract][Full Text] [Related]
10. Predicting transporter-mediated drug interactions: Commentary on: "Pharmacokinetic evaluation of a drug transporter cocktail consisting of digoxin, furosemide, metformin and rosuvastatin" and "Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A".
Zhang L; Sparreboom A
Clin Pharmacol Ther; 2017 Apr; 101(4):447-449. PubMed ID: 27981558
[TBL] [Abstract][Full Text] [Related]
11. Role of pharmacogenetics in variable response to drugs: focus on opioids.
Kadiev E; Patel V; Rad P; Thankachan L; Tram A; Weinlein M; Woodfin K; Raffa RB; Nagar S
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):77-91. PubMed ID: 18370860
[TBL] [Abstract][Full Text] [Related]
12. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
13. Understanding the transport properties of metabolites: case studies and considerations for drug development.
Zamek-Gliszczynski MJ; Chu X; Polli JW; Paine MF; Galetin A
Drug Metab Dispos; 2014 Apr; 42(4):650-64. PubMed ID: 24346835
[TBL] [Abstract][Full Text] [Related]
14. Management of drug-drug interactions: considerations for special populations--focus on opioid use in the elderly and long term care.
Lynch T
Am J Manag Care; 2011 Sep; 17 Suppl 11():S293-8. PubMed ID: 21999762
[TBL] [Abstract][Full Text] [Related]
15. Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development.
Lai Y; Hsiao P
Curr Pharm Des; 2014; 20(10):1577-94. PubMed ID: 23789952
[TBL] [Abstract][Full Text] [Related]
16. Renal transporters in drug disposition, drug-drug interactions, and nephrotoxicity.
Feng B; El-Kattan AF; Radi ZA
Curr Protoc Toxicol; 2012 Aug; Chapter 23():Unit 23.3.1-15. PubMed ID: 22896010
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic drug interactions in palliative care: focus on opioids.
Strouse TB
J Palliat Med; 2009 Nov; 12(11):1043-50. PubMed ID: 19694525
[TBL] [Abstract][Full Text] [Related]
18. Transporters and renal drug elimination.
Lee W; Kim RB
Annu Rev Pharmacol Toxicol; 2004; 44():137-66. PubMed ID: 14744242
[TBL] [Abstract][Full Text] [Related]
19. Impact of drug transporter studies on drug discovery and development.
Mizuno N; Niwa T; Yotsumoto Y; Sugiyama Y
Pharmacol Rev; 2003 Sep; 55(3):425-61. PubMed ID: 12869659
[TBL] [Abstract][Full Text] [Related]
20. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
